
51 - 200 employees
Founded 2016
💰 $205M Post-IPO Equity on 2022-06
Scholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Our most advanced investigational product candidate, apitegromab (SRK-015), a
🕒 April 28
51 - 200
Neuromuscular Account Manager focusing on healthcare providers for SMA treatment strategies. Responsible for developing relationships and driving patient access and market development in the field.
🚗 Michigan – Remote
💵 $210k - $235k / year
💰 $205M Post-IPO Equity on 2022-06
⏰ Full Time
🟠 Senior
🔴 Lead
💰 Account Manager